Literature DB >> 24740685

Gender as a disease modifier in neurofibromatosis type 1 optic pathway glioma.

Michael J Fisher1, Michael Loguidice, David H Gutmann, Robert Listernick, Rosalie E Ferner, Nicole J Ullrich, Roger J Packer, Uri Tabori, Robert O Hoffman, Simone L Ardern-Holmes, Trent R Hummel, Darren R Hargrave, Eric Bouffet, Joel Charrow, Larissa T Bilaniuk, Laura J Balcer, Lucy D'Agostino McGowan, Grant T Liu.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24740685     DOI： 10.1002/ana.24157

Source DB:  PubMed          Journal:  Ann Neurol        ISSN： 0364-5134            Impact factor:   10.422


× No keyword cloud information.
  15 in total

1.  Neurofibromatosis 1-associated optic pathway gliomas.

Authors:  Ben Shofty; Liat Ben Sira; Shlomi Constantini
Journal:  Childs Nerv Syst       Date:  2020-06-11       Impact factor: 1.475

Review 2.  Optic Pathway Gliomas in Neurofibromatosis Type 1: An Update: Surveillance, Treatment Indications, and Biomarkers of Vision.

Authors:  Peter M K de Blank; Michael J Fisher; Grant T Liu; David H Gutmann; Robert Listernick; Rosalie E Ferner; Robert A Avery
Journal:  J Neuroophthalmol       Date:  2017-09       Impact factor: 3.042

Review 3.  Insights into optic pathway glioma vision loss from mouse models of neurofibromatosis type 1.

Authors:  Morgan E Freret; David H Gutmann
Journal:  J Neurosci Res       Date:  2018-04-28       Impact factor: 4.164

Review 4.  Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations.

Authors:  Robert Listernick; Rosalie E Ferner; Grant T Liu; David H Gutmann
Journal:  Ann Neurol       Date:  2007-03       Impact factor: 10.422

Review 5.  CNS Tumors in Neurofibromatosis.

Authors:  Jian Campian; David H Gutmann
Journal:  J Clin Oncol       Date:  2017-06-22       Impact factor: 44.544

Review 6.  Optic Pathway Gliomas in Neurofibromatosis Type 1.

Authors:  Cynthia J Campen; David H Gutmann
Journal:  J Child Neurol       Date:  2018-01       Impact factor: 1.987

7.  Mortality in Children with Optic Pathway Glioma Treated with Up-Front BB-SFOP Chemotherapy.

Authors:  Josué Rakotonjanahary; Emilie De Carli; Matthieu Delion; Chantal Kalifa; Jacques Grill; François Doz; Pierre Leblond; Anne-Isabelle Bertozzi; Xavier Rialland
Journal:  PLoS One       Date:  2015-06-22       Impact factor: 3.240

8.  Estrogen activation of microglia underlies the sexually dimorphic differences in Nf1 optic glioma-induced retinal pathology.

Authors:  Joseph A Toonen; Anne C Solga; Yu Ma; David H Gutmann
Journal:  J Exp Med       Date:  2016-12-06       Impact factor: 14.307

9.  Nonoptic pathway tumors in children with neurofibromatosis type 1.

Authors:  Jasia Mahdi; Manu S Goyal; Jennifer Griffith; Stephanie M Morris; David H Gutmann
Journal:  Neurology       Date:  2020-04-16       Impact factor: 9.910

Review 10.  Neurofibromatosis Type 1-Associated MPNST State of the Science: Outlining a Research Agenda for the Future.

Authors:  Karlyne M Reilly; AeRang Kim; Jaishri Blakely; Rosalie E Ferner; David H Gutmann; Eric Legius; Markku M Miettinen; R Lor Randall; Nancy Ratner; N L Jumbé; Annette Bakker; David Viskochil; Brigitte C Widemann; Douglas R Stewart
Journal:  J Natl Cancer Inst       Date:  2017-08-01       Impact factor: 13.506
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.